Risk factors and clinical outcomes of functional decline during hospitalisation in very old patients with acute decompensated heart failure: an observational study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
16 02 2020
Historique:
entrez: 19 2 2020
pubmed: 19 2 2020
medline: 20 2 2021
Statut: epublish

Résumé

To investigate the prevalence and risk factors of functional decline during hospitalisation and its relationship with postdischarge outcomes in very old patients with acute decompensated heart failure (ADHF) hospitalisation. Prospective cohort study between 1 October 2014 and 31 March 2016. A physician-initiated, multicentre study of consecutive patients admitted for ADHF in 19 hospitals throughout Japan. Among 3555 patients hospitalised for ADHF (median age (IQR), 80 (71-86) years; 1572 (44%) women), functional decline during the index hospitalisation occurred in 528 patients (15%). The primary outcome measure was a composite of all-cause death or heart failure (HF) hospitalisation after discharge. The secondary outcome measures were all-cause death, HF hospitalisation, and a composite of all-cause death or all-cause hospitalisation. The independent risk factors for functional decline included age ≥80 years (OR 2.71; 95% CI 2.09 to 3.51), female (OR 1.32; 95% CI 1.05 to 1.67), prior stroke (OR 1.67; 95% CI 1.28 to 2.19), dementia (OR 2.26; 95% CI 1.74 to 2.95), ambulatory before admission (OR 1.74; 95% CI 1.29 to 2.35), elevated body temperature (OR 1.91; 95% CI 1.31 to 2.79), New York Heart Association class III or IV on admission (OR 1.54; 95% CI 1.07 to 2.22), decreased albumin levels (OR 1.76; 95% CI 1.32 to 2.34), hyponatraemia (OR 1.49; 95% CI 1.10 to 2.03) and renal dysfunction (OR 1.55; 95% CI 1.22 to 1.98), after multivariable adjustment. The cumulative 1-year incidence of the primary outcome in the functional decline group was significantly higher than that in the no functional decline group (50% vs 31%, log-rank p<0.001). After adjusting for baseline characteristics, the higher risk of the functional decline group relative to the no functional decline group remained significant (adjusted HR 1.46; 95% CI 1.24 to 1.71; p<0.001). Independent risk factors of functional decline in very old patients with ADHF were related to both frailty and severity of HF. Functional decline during ADHF hospitalisation was associated with unfavourable postdischarge outcomes. NCT02334891, UMIN000015238.

Identifiants

pubmed: 32066601
pii: bmjopen-2019-032674
doi: 10.1136/bmjopen-2019-032674
pmc: PMC7044905
doi:

Banques de données

ClinicalTrials.gov
['NCT02334891']
UMIN-CTR
['UMIN000015238']

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e032674

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Am Geriatr Soc. 2000 Dec;48(12):1697-706
pubmed: 11129764
ESC Heart Fail. 2017 Aug;4(3):216-223
pubmed: 28772047
JAMA. 2004 Nov 3;292(17):2115-24
pubmed: 15523072
J Am Coll Cardiol. 2012 Nov 13;60(20):2082-9
pubmed: 23083787
J Am Geriatr Soc. 1990 Dec;38(12):1296-303
pubmed: 2123911
JAMA. 2009 Apr 8;301(14):1439-50
pubmed: 19351941
Disabil Rehabil. 1997 May;19(5):175-93
pubmed: 9184783
J Am Geriatr Soc. 1993 Oct;41(10):1065-70
pubmed: 8409151
J Gerontol. 1988 Sep;43(5):S153-61
pubmed: 2971088
Am J Public Health. 1996 Jan;86(1):62-6
pubmed: 8561244
J Am Geriatr Soc. 2003 Apr;51(4):451-8
pubmed: 12657063
Soc Sci Med. 1999 Feb;48(4):445-69
pubmed: 10075171
Arch Intern Med. 1996 Mar 25;156(6):645-52
pubmed: 8629876
J Am Geriatr Soc. 2012 Dec;60(12):2237-45
pubmed: 23176020
J Am Geriatr Soc. 2002 Dec;50(12):1978-86
pubmed: 12473009
Am Heart J. 2017 Mar;185:130-139
pubmed: 28267466
Am J Public Health. 2002 Aug;92(8):1244-5
pubmed: 12144976
J Gerontol A Biol Sci Med Sci. 2002 Sep;57(9):M569-77
pubmed: 12196493
Eur J Heart Fail. 2015 Nov;17(11):1104-13
pubmed: 26235192
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
BMJ. 2009 Jan 22;338:b50
pubmed: 19164393
Eur J Heart Fail. 2014 Jan;16(1):41-8
pubmed: 24453097
Circ J. 2018 Oct 25;82(11):2811-2819
pubmed: 30259898
Circ J. 2006 Apr;70(4):384-8
pubmed: 16565552
J Am Geriatr Soc. 2000 May;48(5):493-8
pubmed: 10811541
JAMA Netw Open. 2019 Jun 5;2(6):e195892
pubmed: 31225889
Eur Heart J. 2014 Feb;35(7):416-8
pubmed: 24334714
J Am Geriatr Soc. 2009 Oct;57(10):1757-66
pubmed: 19694869
BMJ. 2010 Apr 20;340:c1718
pubmed: 20406866
N Engl J Med. 2013 Oct 3;369(14):1306-16
pubmed: 24088092

Auteurs

Hidenori Yaku (H)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine and Faculty of Medicine, Kyoto, Japan.
Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.

Takao Kato (T)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine and Faculty of Medicine, Kyoto, Japan tkato75@kuhp.kyoto-u.ac.jp.

Takeshi Morimoto (T)

Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan.

Yasutaka Inuzuka (Y)

Cardiovascular Medicine, Shiga General Hospital, Moriyama, Japan.

Yodo Tamaki (Y)

Cardiology, Public Interest Incorporated Foundation Tenri Hospital, Tenri, Japan.

Neiko Ozasa (N)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine and Faculty of Medicine, Kyoto, Japan.

Erika Yamamoto (E)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine and Faculty of Medicine, Kyoto, Japan.

Yusuke Yoshikawa (Y)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine and Faculty of Medicine, Kyoto, Japan.

Takeshi Kitai (T)

Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.

Masashi Kato (M)

Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.

Tomoyuki Ikeda (T)

Department of Cardiology, Hikone Municipal Hospital, Hikone, Japan.

Yutaka Furukawa (Y)

Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.

Yoshihisa Nakagawa (Y)

Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan.

Yukihito Sato (Y)

Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.

Koichiro Kuwahara (K)

Cardiovascular Medicine, Shinshu University Graduate School of Medicine, School of Medicine, Matsumoto, Japan.

Takeshi Kimura (T)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine and Faculty of Medicine, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH